Bio-Techne (TECH) Research & Development (2009 - 2026)
Bio-Techne (TECH) recorded quarterly Research & Development of $23.5 million in Q1 2026, up 1.43% quarter-over-quarter from $23.1 million in Q4 2025, and down 4.57% on a YoY basis from $24.6 million in Q1 2025.
Bio-Techne (TECH) Research & Development (2009 - 2026) Analysis & Trends
Bio-Techne's Research & Development history runs 18 years deep, the most recent figure standing at $23.5 million for Q1 2026.
- In Q1 2026, Research & Development fell 4.57% year-over-year to $23.5 million; the TTM figure through Mar 2026 stood at $96.9 million (down 0.62% YoY), while the FY2025 annual figure was $99.5 million, up 2.93% from the prior year.
- Research & Development was $23.5 million for Q1 2026 at Bio-Techne, up from $23.1 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $26.0 million in Q2 2025 to a low of $21.7 million in Q1 2022.
- Historically, Research & Development has averaged $23.8 million across 5 years, with a median of $23.9 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Research & Development climbed 27.5% in 2022, then declined 7.56% in 2025.
- A 5-year view of Research & Development shows it stood at $22.5 million in 2022, then grew by 2.03% to $22.9 million in 2023, then grew by 9.16% to $25.0 million in 2024, then slipped by 7.56% to $23.1 million in 2025, then increased by 1.43% to $23.5 million in 2026.
- The last three Research & Development figures came in at $23.5 million (Q1 2026), $23.1 million (Q4 2025), and $24.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -2.30 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 1.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -58.00 Mn |
| 10 | Bio-Techne | 9.04 Bn | 8.83 Bn | 208.29 Mn | 23.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.46 Mn |
| Dec 31, 2025 | 23.13 Mn |
| Sep 30, 2025 | 24.24 Mn |
| Jun 30, 2025 | 26.03 Mn |
| Mar 31, 2025 | 24.58 Mn |
| Dec 31, 2024 | 25.02 Mn |
| Sep 30, 2024 | 23.87 Mn |
| Jun 30, 2024 | 23.99 Mn |
| Mar 31, 2024 | 25.76 Mn |
| Dec 31, 2023 | 22.92 Mn |
| Sep 30, 2023 | 24.00 Mn |
| Jun 30, 2023 | 23.42 Mn |
| Mar 31, 2023 | 22.71 Mn |
| Dec 31, 2022 | 22.46 Mn |
| Sep 30, 2022 | 23.90 Mn |
| Jun 30, 2022 | 23.15 Mn |
| Mar 31, 2022 | 21.74 Mn |
| Dec 31, 2021 | 20.65 Mn |
| Sep 30, 2021 | 21.60 Mn |
| Jun 30, 2021 | 20.72 Mn |